Background There are no published reference intervals for concentrations of alpha-fetoprotein (AFP) in the cerebrospinal fluid (CSF) of normal infants. The presence of abnormal concentrations of AFP in plasma or CSF may indicate the presence of a teratoma or a germ cell tumour with yolk sac elements. We measured CSF AFP in infants who did not have malignancy in order to determine its reference intervals.
Introduction
Alpha-fetoprotein (AFP) was ¢rst described during the investigation of serum proteins in the human fetus by Bergstrand and Czar in 1956. 1 In 1963, Abelev's description 2 of an oncofetal antigen arising in an experimental liver tumour immunologically identical to a normal fetal protein represented the introduction of a potential 'cancer marker' in modern medicine.
Synthesis of AFP occurs in the human fetal yolk sac, hepatocytes and gastrointestinal mucosa during the early ¢rst trimester, but takes place predominantly in the hepatocytes after the eighth week. 3, 4 AFP is also known to exist in the epithelial cells of the human fetal choroid plexus but declines in concentration in these cells as gestation progresses. 5 In fetal serum, AFP reaches a peak concentration of about 2,500,000 kIU/L by the ¢fteenth week of pregnancy and decreases thereafter, in part due to the rapid increase in fetal size. AFP concentrations range from a mean of approximately 40,000 kIU/L at birth to normal adult levels by about 8 months of age. 6 The rapid physiological fall in serum AFP concentration during the ¢rst 8 months of postnatal life is a potential source of 'false-positive'error in the diagnostic evaluation of infants in whom physiological elevations of AFP up to many times the normal adult range may be observed. Elevated plasma AFP concentrations have been reported in infancy in conditions such as neonatal hepatitis, biliary atresia and ataxiatelangiectasia. 7, 8 AFP is not an acute-phase reactant. 9 Wu et al. 6 monitored serum AFP concentrations in 32 normal babies consecutively from 2 to 3 days to 4 months after birth. They also measured serum AFP concentrations in 116 random specimens from infants with normal liver enzymes to establish age-related reference ranges. Although the rate of decline was similar among patients of similar ages, individual concentrations were highly variable and found to be independent of gestational age, weight or type of milk feeds. They demonstrated that the plasma AFP concentrations reached adult levels after 8 months of age and concluded that the change in the rate of AFP degradation during the ¢rst month of life indicated that a considerable amount of physiological AFP synthesis continued after birth.
To date, there have been no published reference intervals for AFP concentrations in the cerebrospinal £uid (CSF) of newborns, and the extent to which the higher but physiological concentrations of plasma AFP in infants in£uence AFP concentrations in the CSF has not been investigated previously. The aims of this study were to address both these questions in order to assist in the interpretation of CSF tumour marker studies in very young patients with suspected yolk saccontaining CNS germ cell tumours or teratomas secreting AFP. Teratomas are said to be the most common CNS tumour in the neonatal period. 10 Therefore, ¢nding a raised CSF AFP concentration may assist in diagnosis, particularly when the tumour is di⁄cult to biopsy.
Patients and methods
The CSF and lithium heparin plasma used in this study were obtained from a total of 128 infants at the Children's Hospital at Westmead, Sydney, as part of their essential diagnostic investigations for a variety of disorders including sepsis but excluding malignancy. CSF was collected by lumbar puncture and those specimens containing more than 5000 Â10 6 /L red blood cells were excluded. Both CSF and plasma samples were centrifuged at 3000 rotations per minute (rpm) for 10--15 min and the supernatant £uid stored at 41C until the time of analysis. Ethical approval to use these left-over samples was obtained from the Institutional Ethics Committee of the Children's Hospital at Westmead.
Ninety-one infants (51 boys) aged 1--110 days had CSF AFP measurements. Plasma AFP concentrations were measured in 94 infants (56 boys) aged1--103 days. AFP concentrations were determined in paired CSFand plasma samples in 60 infants. Two infants had measurements on two separate occasions. The computer records of all the subjects were used to record diagnosis and gestation.Where gestation was recorded, postnatal age was later corrected to account for either prematurity or postmaturity, so that in some cases the postnatal age became 'negative'. Infants who did not have a speci-¢c gestational age stated in their medical record were assumed to be born at term (40 weeks).
CSF and plasma AFP were measured in singlicate using a microparticle enzyme immunoassay on an Ax-Sym analyser (Abbott Laboratories, Abbott Park, IL, USA). The AFP calibrators were referenced to the World Health Organization First International Standard 72/ 225. The lower limit of sensitivity of this assay is 0.3 kIU/L. The assay was validated for use in CSF ¢rstly by diluting the highest calibrator (AFP 291kIU/L) 101 times in CSF containing no AFP. AFP was then measured in this CSF and a result of 3 kIU/L was obtained (mean of four assays). Secondly plasma containing a high AFP concentration was diluted 101 times, ¢rst with CSF containing no AFP, and then with the recommended Abbott diluent. The result for the CSF diluted sample was 25 kIU/L, while that for the recommended diluent was 27 kIU/L (mean of four assays). In this laboratory, the interassay coe⁄cients of variation for the AFP assay are 7.7%, 11.2% and 6.8% for mean AFP concentrations of 15 kIU/L, 63 kIU/L and 141kIU/L, respectively.
The SPSS statistical software (version 11.5.1; SPSS Inc., Chicago, IL, USA) was used to determine the mean, median,5th and 95th percentiles and range for CSF and plasma AFP concentrations in infants of corrected age À69 to 31days and infants of corrected age 32--110 days.
Microsoft Excel was used to graphically explore the relationships between age/corrected age and the concentrations of AFP in plasma and CSF, and to determine the exponential equations that best ¢t the data. The exponential equations had the format: y ¼ C 0 e Àkx , where y ¼ CSF or plasma AFP concentration, x ¼ age or corrected age (days) and C 0 is the equation-determined AFP concentration at age/corrected age zero. Using the constant (k) from the exponential equation, it was possible to determine the half-life (t 1=2 ) of the decline in AFP concentrations as follows: t 1=2 ¼ 0.693/k.
The ratio of plasma to CSFAFP was calculated for the 60 infants who had paired plasma and CSF AFP measurements. For plasma AFPs less than 100 kIU/L (n¼14), CSF AFP was less than or equal to 1kIU/L in all but one instance. These ratios may therefore have been inaccurate and so were not included in the analysis.
Results
The CSF concentrations of AFP are plotted against postnatal age in Figure 1a . This ¢gure shows some outlying results in babies over one month of age. Each of these higher concentrations occurred in preterm infants, and when ages were corrected for gestation a more regular decline of AFP values according to age was demonstrated ( Figure 1b ). Similar results for plasma AFP (uncorrected and corrected for gestational age) are shown in Figures 2a and 2b . The semilogarithmic plots show a statistically signi¢cant exponential decrease in AFP with time when age is corrected for gestation, both in CSF and plasma. The trendlines and equations in Figures 1b and 2b describe this exponential decline and from these equations the half-lives of decline in AFP concentrations were calculated to be 11 days in CSF and 13 days in plasma.
The subjects were also divided into two groups (À69 to 31 days and 32 to 110 days) according to corrected postnatal age and the mean and median CSF and plasma AFP concentrations calculated for each group, along with the range and the 5th to 95th percentiles. These results are shown in Table 1 . Figure 3 shows a scatterplot of the ratio of plasma to CSF AFP concentration against corrected gestational age in 46 infants who had plasma AFPs greater than 100 kIU/L. The ratio of plasma to CSFAFP concentration ranged from 20 to 376, with a median value of 89 for babies less than 31 corrected days old and a median value of 156 for babies greater than 31 days old.
Discussion
This study demonstrates that AFP concentrations in lumbar CSF in the ¢rst three months of life are usually 5% or less than the corresponding values in plasma. To our knowledge, there have been no similar studies performed. Bell et al. 11 investigated the developmental pro-¢le of various plasma proteins, including AFP, in human fetal and neonatal CSF and blood and concluded that the human fetal blood--brain barrier matures early. However, this study only included neonates up to 41 weeks gestation who had lumbar punctures within 24 h of birth. In our study, when the plasma AFP was 100 kIU/L or more, the ratio of plasma to CSF AFP was at least 20:1. As shown in Figure 3 , higher ratios were seen in more mature babies, indicating that the blood--brain barrier is not as e¡ective in premature infants. This conclusion is also supported by the fact that total protein concentrations are higher in the CSFof premature babies. 12 Although our ¢ndings suggest that the blood--brain barrier is e¡ective in excluding most of the plasma AFP from the CSF, there remains the possibility that some AFP is being produced locally in the choroid plexus. As Figure 1 shows, there is a rapid postnatal decline in CSF AFP concentrations, with a half-life of about 11 days so that by 5--6 weeks of age, CSF AFP concentrations are approaching those found in adult plasma. It is interesting to note that when the CSF data were ¢rst plotted, a small number of patients over 6 weeks of age had higher than expected AFP concentrations. However, it was then discovered that these subjects had been born prematurely, and when corrections were made for this the results were similar to all the others. Similar ¢ndings were noted for the plasma AFP measurements. In interpreting both CSF and plasma AFP results in babies, therefore, it is important to correct for prematurity. This e¡ect on plasma AFP 11 has already been published.
There have only been a few papers on reference intervals for plasma/serum AFP in infancy. 6, 13, 14, 15 Wu et al. concluded that serum AFP disappeared rapidly after birth, but it was not until 8 months of age that AFP concentrations in infants approached adult levels. These investigators reported that AFP concentrations declined with half-lives of 5.5 days between birth and 2 weeks, 11 days between 2 weeks and 2 months and 33 days between 2 and 4 months of age. Unlike Wu et al., we found a relatively constant exponential decline in plasma AFP, with a half-life of 13 days between birth and 96 days (corrected for gestation).
How can our ¢ndings be applied in the clinical situation? We suggest that for babies over 5--6 weeks of age (corrected for prematurity), CSF AFP concentrations should be in the region of 12 kIU/L or less. By the age of 2 months (corrected for prematurity), all CSF AFP concentrations should be less than 3 kIU/L. This is provided there is no disruption of the normal blood-brain barrier, which may be indicated by the ¢nding of an elevated protein concentration or red blood cells in the CSF. As the ¢ndings indicate that AFP disappears quickly from CSF in the ¢rst 2 months of life, it is reasonable to conclude that older children and adults should have no AFP in their CSF. This conclusion can be employed when CSF AFP is measured as a tumour marker in this group of patients with CNS tumours.
It should be noted that our ¢ndings should only be applied to lumbar CSF and not to ventricular CSF, which we have not studied. The results of this study are preliminary --further experience is needed in studying CSFAFP concentrations in patients with cerebral tumours of all kinds.
In conclusion, we have de¢ned reference intervals for AFP in the CSF of babies, and de¢ned its half-life. Taken in conjunction with measurements of plasma AFP, these ¢ndings may assist in the diagnosis of congenital CNS tumours. Corrected age (days) Ratio of plasma and CSF AFP Figure 3 . Ratios of plasma AFP to CSF AFP plotted against age corrected for gestation. Note: Only those ratios where the plasma AFP was >100 kIU/L have been included. One outlier point, an infant of À31 days, has been removed from this analysis.
